Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Jan L. Sabran in Immunochromatographic Assay Technology
Introduction: Jan L. Sabran, an accomplished inventor based in San Diego, CA, has made significant strides in the field of immunoassay technology. With a focus on enhancing the sensitivity of diagnostic tests, her work is paving the way for advanced medical diagnostics that can improve patient outcomes.
Latest Patents: Jan L. Sabran holds a patent titled "Controlled Sensitivity Immunochromatographic Assay." This inventive concept introduces an improved one-step immunochromatographic assay that facilitates the binding of a predetermined amount of analyte to an antibody. This innovation allows for controlled assay sensitivity, which is particularly beneficial for fecal occult blood testing. In this system, antibodies specific to the desired analyte are precisely deposited on the sample pad of the reaction unit. If the amount of analyte in the sample exceeds a predefined threshold, it passes through the sample pad, reaching a membrane where it reacts with an antibody-coated latex and a second immobilized antibody, generating a positive signal.
Career Highlights: Jan L. Sabran's professional journey is marked by her association with Quidel Corporation, where she has had the opportunity to work on groundbreaking innovations. Her dedication and expertise have led her to focus on developing diagnostic solutions that align with contemporary medical needs.
Collaborations: Throughout her career, Jan has collaborated with distinguished professionals, including Hans R. Boehringer and Ya-Chen Hsu. These collaborations have helped foster an environment of innovation and excellence, further enhancing the potential of her inventions.
Conclusion: Jan L. Sabran's contributions to the field of immunochromatographic assays exemplify the power of innovation in medical diagnostics. Her patent highlights her commitment to improving diagnostic methods, ensuring that healthcare providers can offer precise and effective testing to their patients. As her career progresses, the impact of her work is likely to resonate within the medical community, inspiring future innovations in the field.